Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

NAZAL SPRAY

Approval Number

SIN03722P

Drug Name

NAZAL SPRAY

Product Name

NAZAL SPRAY

Approval Date

November 6, 1989

Registrant

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

Registrant

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SPRAY

Route of Administration

NASAL

Medical Information

ATC Code

R01AB02

ATC Item Name

naphazoline

Manufacturer Information

Pharmaceutical Manufacturer

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Manufacturers

SATO PHARMACEUTICAL CO LTD

Active Ingredients

Ingredient Name

CHLORPHENIRAMINE MALEATE

Strength

500 mg/100 ml

Drug MonographChlorpheniramine

Ingredient Name

NAPHAZOLINE HCl

Strength

50 mg/100 ml

Drug MonographNaphazoline

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy